Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 192

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 192
---
     |   | December 31, 
         2023 |   |
|:------------------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Lab equipment                       |     | $ |      151,134 |   |     | $ |      131,963 |   |
| Total property and equipment, gross |     |   |      151,134 |   |     |   |      131,963 |   |
| Accumulated depreciation            |     |   |      (94,802 | ) |     |   |      (66,879 | ) |
| Total property and equipment, net   |     | $ |       56,332 |   |     | $ |       65,084 |   |

Depreciation expense was $27,923 for year ended December 31, 2024 and $25,049 for the year ended December 31, 2023. Accrued Expenses Accrued expenses consisted of the following:

|                                      |     |   | December 31, 
         2024 |     |   | December 31, 
         2023 |
|:-------------------------------------|:----|:--|-------------:|:----|:--|-------------:|
| Accrued payroll and related expenses |     | $ |      835,724 |     | $ |      768,720 |
| Accrued clinical study expenses      |     |   |      183,824 |     |   |       10,268 |
| Accrued professional fees            |     |   |       67,049 |     |   |      219,888 |
| Accrued clinical development costs   |     |   |       41,203 |     |   |      153,584 |
| Total accrued expenses               |     | $ |    1,127,800 |     | $ |    1,152,460 |

4. Commitments and Contingencies Lease Commitments The Company leases 2,140 square feet of laboratory space located at 11011 Torreyana Road, Suite 102, San Diego, California (the “Lease”). In December 2024, the Company signed an amendment extending the Lease until February 28, 2025, with a base monthly rent equal to $5,350. The Company is required to maintain a security deposit of $5,